Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-15T14:06:34.860Z.
Calculation as of: 2026-09-15T14:06:34.860Z.
Quote observation: 2026-09-15T14:05:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d7d60f6e5c70f6bfb7038272385ee8b288b140a1e50095f2d4f01ea6be162efe
PEG RATIO
N/A
Medline Inc.
Market Cap
$27.29B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Medline Inc. (MDLN) | $27.29B | N/A |
| Quest Diagnostics Incorporated (DGX)vs › | $26.91B | N/A |
| Mettler-Toledo International Inc. (MTD)vs › | $26.52B | N/A |
| Labcorp Holdings Inc. (LH)vs › | $26.08B | N/A |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.91B | N/A |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.30B | N/A |
| Incyte Corporation (INCY)vs › | $24.40B | N/A |
| BioNTech SE (BNTX)vs › | $24.16B | N/A |
| Zoetis Inc. (ZTS)vs › | $30.57B | N/A |
| Waters Corporation (WAT)vs › | $31.23B | N/A |
PEG Ratio
N/A
P/E Ratio
37.5
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute